Clinical course and long-term outcome of hantavirus-associated nephropathia Epidemica, Germany

Emerging Infectious Diseases

Volumn 21, Issue 1, 2015, Pages 76-83

  Latus, Joerg ^a   Schwab, Matthias ^b,c   Tacconelli, Evelina ^c   Pieper, Friedrich Michael ^a   Wegener, Daniel ^a   Dippon, Juergen ^d   Müller, Simon ^d   Zakim, David ^a   Segerer, Stephan ^e   Kitterer, Daniel ^a   Priwitzer, Martin ^f   Mezger, Barbara ^f   Walter Frank, Birgit ^g   Corea, Angela ^h   Wiedenmann, Albrecht ^h   Brockmann, Stefan ⁱ   Pöhlmann, Christoph ^a   Alscher, M Dominik ^a   Braun, Niko ^a  

^a ROBERT BOSCH HOSPITAL   (Germany)

^b DR MARGARETE FISCHER BOSCH INSTITUTE OF CLINICAL PHARMACOLOGY   (Germany)

^c UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^d UNIVERSITY OF STUTTGART   (Germany)

^e UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^f State Health Authority   (Germany)

^g Local Health Authority   (Germany)

^h Local Health Authority   (Germany)

ⁱ Local Health Authority   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ACUTE KIDNEY FAILURE; ADULT; ARTICLE; BACKACHE; BLOOD PRESSURE; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE COURSE; EPISTAXIS; FEMALE; FEVER; FOLLOW UP; GLOMERULONEPHRITIS; HANTAVIRUS INFECTION; HEMATURIA; HEMORRHAGIC FEVER; HUMAN; HUMORAL IMMUNITY; HYPERTENSION; LIMB PAIN; LYMPHOCYTOPENIA; MAJOR CLINICAL STUDY; MALE; MONOCYTOSIS; NAUSEA AND VOMITING; NEPHROPATHIA EPIDEMICA; OUTCOME ASSESSMENT; PHENOTYPE; PROSPECTIVE STUDY; PROTEINURIA; PUUMALA VIRUS; THROMBOCYTOPENIA; GERMANY; HEMORRHAGIC FEVER WITH RENAL SYNDROME; IMMUNOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; URINE; VIROLOGY;

ADULT; CROSS-SECTIONAL STUDIES; FEMALE; GERMANY; HEMATURIA; HEMORRHAGIC FEVER WITH RENAL SYNDROME; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 84919623519     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid2101.140861     Document Type: Article

References (40)

1. Schmaljohn CS, Dalrymple JM. Analysis of Hantaan virus RNA: evidence for a new genus of Bunyaviridae. Virology. 1983;131:482-91. http://dx.doi.org/10.1016/0042-6822(83)90514-7
2. Krüger DH, Ulrich R, Lundkvist AA. Hantavirus infections and their prevention. Microbes Infect. 2001;3:1129-44. http://dx.doi.org/10.1016/S1286-4579(01)01474-5
3. Peters CJ, Simpson GL, Levy H. Spectrum of hantavirus infection: hemorrhagic fever with renal syndrome and hantavirus pulmonary syndrome. Annu Rev Med. 1999;50:531-45. http://dx.doi.org/10.1146/annurev.med.50.1.531
4. Watson DC, Sargianou M, Papa A, Chra P, Starakis I, Panos G. Epidemiology of hantavirus infections in humans: a comprehensive, global overview. Crit Rev Microbiol. 2014;40:261-72. http://dx.doi.org/10.3109/1040841X.2013.783555
5. Ettinger J, Hofmann J, Enders M, Tewald F, Oehme RM, Rosenfeld UM, et al. Multiple synchronous outbreaks of Puumala virus, Germany, 2010. Emerg Infect Dis. 2012;18:1461-4. http://dx.doi.org/10.3201/eid1809.111447
6. Boone I, Wagner-Wiening C, Reil D, Jacob J, Rosenfeld UM, Ulrich RG, et al. Rise in the number of notified human hantavirus infections since October 2011 in Baden-Wurttemberg, Germany. Euro Surveill. 2012;17:20180.
7. Krüger DH, Ulrich RG, Hofmann J. Hantaviruses as zoonotic pathogens in Germany. Dtsch Arztebl Int. 2013;110:461-7.
8. Vapalahti O, Mustonen J, Lundkvist A, Henttonen H, Plyusnin A, Vaheri A. Hantavirus infections in Europe. Lancet Infect Dis. 2003;3:653-61. http://dx.doi.org/10.1016/S1473-3099(03)00774-6
9. Krautkrämer E, Zeier M, Plyusnin A. Hantavirus infection: an emerging infectious disease causing acute renal failure. Kidney Int. 2013;83:23-7. http://dx.doi.org/10.1038/ki.2012.360
10. Braun N, Haap M, Overkamp D, Kimmel M, Alscher MD, Lehnert H, et al. Characterization and outcome following Puumala virus infection: a retrospective analysis of 75 cases. Nephrol Dial Transplant. 2010;25:2997-3003. http://dx.doi.org/10.1093/ndt/gfq118
11. Hjertqvist M, Klein SL, Ahlm C, Klingstrom J. Mortality rate patterns for hemorrhagic fever with renal syndrome caused by Puumala virus. Emerg Infect Dis. 2010;16:1584-6. http://dx.doi.org/10.3201/eid1610.100242
12. Makary P, Kanerva M, Ollgren J, Virtanen MJ, Vapalahti O, Lyytikainen O. Disease burden of Puumala virus infections, 1995-2008. Epidemiol Infect. 2010;138:1484-92. http://dx.doi.org/10.1017/S0950268810000087
13. Mustonen J, Brummer-Korvenkontio M, Hedman K, Pasternack A,Pietila K, Vaheri A. Nephropathia epidemica in Finland: a retrospective study of 126 cases. Scand J Infect Dis. 1994;26:7-13. http://dx.doi.org/10.3109/00365549409008583
14. Settergren B, Juto P, Trollfors B, Wadell G, Norrby SR. Hemorrhagic complications and other clinical findings in nephropathia epidemica in Sweden: a study of 355 serologically verified cases. J Infect Dis. 1988;157:380-2. http://dx.doi.org/10.1093/infdis/157.2.380
15. Rasche FM, Uhel B, Kruger DH, Karges W, Czock D, Hampl W, et al. Thrombocytopenia and acute renal failure in Puumala hantavirus infections. Emerg Infect Dis. 2004;10:1420-5. http://dx.doi.org/10.3201/eid1008.031069
16. Ala-Houhala I, Koskinen M, Ahola T, Harmoinen A, Kouri T, Laurila K, et al. Increased glomerular permeability in patients with nephropathia epidemica caused by Puumala hantavirus. Nephrol Dial Transplant. 2002;17:246-52. http://dx.doi.org/10.1093/ndt/17.2.246
17. Niklasson B, Hellsten G, LeDuc J. Hemorrhagic fever with renal syndrome: a study of sequelae following nephropathia epidemica. Arch Virol. 1994;137:241-7. http://dx.doi.org/10.1007/BF01309472
18. Mäkelä S, Ala-Houhala I, Mustonen J, Koivisto AM, Kouri T, Turjanmaa V, et al. Renal function and blood pressure five years after Puumala virus-induced nephropathy. Kidney Int. 2000;58:1711-8. http://dx.doi.org/10.1046/j.1523-1755.2000.00332.x
19. Miettinen MH, Mäkelä SM, Ala-Houhala IO, Huhtala HS, Koobi T, Vaheri AI, et al. Ten-year prognosis of Puumala hantavirus-induced acute interstitial nephritis. Kidney Int. 2006;69:2043-8. http://dx.doi.org/10.1038/sj.ki.5000334
20. Lähdevirta J. Nephropathia epidemica in Finland. A clinical histological and epidemiological study. Ann Clin Res. 1971;3:1-54.
21. Lähdevirta J, Collan Y, Jokinen EJ, Hiltunen R. Renal sequelae to nephropathia epidemica. Acta Pathol Microbiol Scand [A]. 1978;86:265-71.
22. Rubini ME, Jablon S, Mc DM. Renal residuals of acute epidemic hemorrhagic fever. Arch Intern Med. 1960;106:378-87. http://dx.doi.org/10.1001/archinte.1960.03820030066011
23. Kleinknecht D, Rollin PE. Hypertension after hemorrhagic fever with renal syndrome. Nephron. 1992;61:121. http://dx.doi.org/10.1159/000186853
24. Krautkrämer E, Grouls S, Urban E, Schnitzler P, Zeier M. No gender-related differences in the severity of nephropathia epidemica, Germany. BMC Infect Dis. 2013;13:457. http://dx.doi.org/10.1186/1471-2334-13-457
25. Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves J, Hill MN, et al. Recommendations for blood pressure measurement in humans and experimental animals: part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Hypertension. 2005;45:142-61. http://dx.doi.org/10.1161/01.HYP.0000150859.47929.8e
26. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289:2560-72. http://dx.doi.org/10.1001/jama.289.19.2560
27. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P. Acute renal failure-definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2004;8:R204-12. http://dx.doi.org/10.1186/cc2872
28. Outinen TK, Tervo L, Mäkelä S, Huttunen R, Mäenpää N, Huhtala H, et al. Plasma levels of soluble urokinase-type plasminogen activator receptor associate with the clinical severity of acute Puumala hantavirus infection. PLoS ONE. 2013;8:e71335. http://dx.doi.org/10.1371/journal.pone.0071335
29. Outinen TK, Mäkelä SM, Ala-Houhala IO, Huhtala HS, Hurme M, Paakkala AS, et al. The severity of Puumala hantavirus induced nephropathia epidemica can be better evaluated using plasma interleukin-6 than C-reactive protein determinations. BMC Infect Dis. 2010;10:132. http://dx.doi.org/10.1186/1471-2334-10-132
30. Krautkrämer E, Grouls S, Stein N, Reiser J, Zeier M. Pathogenic old world hantaviruses infect renal glomerular and tubular cells and induce disassembling of cell-to-cell contacts. J Virol. 2011;85:9811-23. http://dx.doi.org/10.1128/JVI.00568-11
31. Vaheri A, Strandin T, Hepojoki J, Sironen T, Henttonen H, Mäkelä S,et al. Uncovering the mysteries of hantavirus infections. Nat Rev Microbiol. 2013;11:539-50. http://dx.doi.org/10.1038/nrmicro3066
32. Turčinov D, Puljiz I, Markotić A, Kuzman I, Begovac J. Clinical and laboratory findings in patients with oliguric and non-oliguric hantavirus haemorrhagic fever with renal syndrome: an analysis of 128 patients. Clin Microbiol Infect. 2013;19:674-9. http://dx.doi.org/10.1111/j.1469-0691.2012.03994.x
33. Heyman P, Vaheri A, Lundkvist A, Avsic-Zupanc T. Hantavirus infections in Europe: from virus carriers to a major public-health problem. Expert Rev Anti Infect Ther. 2009;7:205-17. http://dx.doi.org/10.1586/14787210.7.2.205
34. Hautala N, Kauma H, Vapalahti O, Mahonen SM, Vainio O, Vaheri A, et al. Prospective study on ocular findings in acute Puumala hantavirus infection in hospitalised patients. Br J Ophthalmol. 2011;95:559-62. http://dx.doi.org/10.1136/bjo.2010.185413
35. Wolf-Maier K, Cooper RS, Banegas JR, Giampaoli S, Hense HW, Joffres M, et al. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA. 2003;289:2363-9. http://dx.doi.org/10.1001/jama.289.18.2363
36. Elgh F, Linderholm M, Wadell G, Tarnvik A, Juto P. Development of humoral cross-reactivity to the nucleocapsid protein of heterologous hantaviruses in nephropathia epidemica. FEMS Immunol Med Microbiol. 1998;22:309-15. http://dx.doi.org/10.1111/ j.1574-695X.1998.tb01220.x
37. Elgh F, Lundkvist A, Alexeyev OA, Stenlund H, Avsic-Zupanc T, Hjelle B, et al. Serological diagnosis of hantavirus infections by an enzyme-linked immunosorbent assay based on detection of immunoglobulin G and M responses to recombinant nucleocapsid proteins of five viral serotypes. J Clin Microbiol. 1997;35:1122-30.
38. Maes P, Clement J, Gavrilovskaya I, Van Ranst M. Hantaviruses: immunology, treatment, and prevention. Viral Immunol. 2004;17:481-97. http://dx.doi.org/10.1089/vim.2004.17.481
39. Klempa B, Meisel H, Rath S, Bartel J, Ulrich R, Kruger DH. Occurrence of renal and pulmonary syndrome in a region of northeast Germany where Tula hantavirus circulates. J Clin Microbiol. 2003;41:4894-7. http://dx.doi.org/10.1128/JCM.41.10.4894- 4897.2003
40. Klempa B, Schutt M, Auste B, Labuda M, Ulrich R, Meisel H, et al. First molecular identification of human Dobrava virus infection in central. J Clin Microbiol. 2004;42:1322-5. http://dx.doi.org/10.1128/JCM.42.3.1322-1325.2004